Limited reporting of major harms in studies of initial combination antiretroviral therapy: a systematic review

摘要

Objectives: Risk-benefit assessment of combination antiretroviral therapy (cART) requires consideration of all potential serious harms. Studies of initial cART may permit identification of associations between particular regimens and uncommon harms, but only if comprehensively reported in the public domain.